This Week in PLOS | GenomeWeb

This Week in PLOS

A number of microRNAs can repress translation of Twist1, a proto-oncogene whose upregulation is linked to resistance to cancer drugs, report Aarhus University researchers in PLOS One. In a number of cell lines, the researchers found that miR-145a-5p, miR-151-5p and a combination of miR-145a-5p and miR-151-5p or of miR-151-5p and miR-337-3p could repress the expression of the oncogene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

This Week in PLOS

This Week in PLOS

This Week in PLOS

This Week in Science

Make What You Want

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.